Recently, Scamblix, a specific targeted BCR-ABL1 protein myristoyl pocket (STAMP) inhibitor, has been developed for the treatment of chronic myeloid leukemia (CML) ® Asciminib, located in the Lecheng pilot area of Ruijin Hainan Hospital (Boao Research Hospital), will provide treatment options for Chinese doctors and experts, and bring hope for more patients with chronic myelopathy. As the world's first and only approved STAMP inhibitor, Scamblix ® (Asciminib), after being approved by the US FDA

According to the unified deployment of the Provincial Party Committee, on February 6th, Jia Ning, Secretary and Director of the Party Committee of the Lecheng Pilot District Management Bureau, presided over the 2022 Democratic Life Meeting of Party Members and Leading Cadres of the Lecheng Management Bureau. Yan Zhi, Lv Xiaolei, Fu Zhu, Fu Gan, and Yang Yibing, members of the Party Committee leadership team of the Lecheng Pioneer District Management Bureau, attended the meeting.

Zhu Chenchen (pseudonym) is a 20-year-old young man who, in March 2019, was in his prime when he suffered from DLBCL (diffuse large B-cell lymphoma). In November 2020, Zhu Chenchen arrived at Evergrande International Hospital located in the pilot area of Lecheng. Doctor, I have added many groups, including the communication group for lymphoma patients' family members and the communication group for lymphoma recurrence and difficult to treat patients. Patients all say that over 90% of them are m

On January 13th, Shulan Medical Group completed the 5-year custody operation of Boao Super Hospital, and the management team held a five-year work summary meeting with Boao Super Hospital. Hainan has established a high standard construction of the Boao Lecheng International Medical Tourism Pilot Zone, innovated hospital operation and management models, created a "new model of shared hospitals - Boao Super Hospital", explored the innovation of hospital operation and management system based on the

On December 7, 2022, the National Food and Drug Administration and the Hainan Provincial Government jointly held the fourth meeting of the 2022 Leading Group for the Clinical Real World Data Application Pilot Work of Drugs and Medical Devices, summarizing the progress of the clinical real world data application pilot work since the third leading group meeting, and studying and deploying the next steps to meet the requirements of the 20th National Congress of the Communist Party of China, Assist

In order to fully leverage the respective advantages of Lecheng Pilot Zone and Haikou National High tech Zone, actively explore the new model of "enclave economy" in the park, and promote the development of Hainan's biopharmaceutical industry, on the afternoon of November 16th, the Hainan Provincial Development and Reform Commission Hainan Provincial Drug Administration Lecheng Pilot Zone Management Bureau Haikou National High tech Zone four-way linkage symposium was held in Lecheng, Boao.